Iovance Biotherapeutics, Inc. IOVA Return on invested capital

Return on invested capital at other companies

Bristol-Myers SquibbBMY

16.7%+8.4pp

Gilead SciencesGILD

-6.7%-24.7pp

Cullinan Therapeutics, Inc.CGEM

-58%+22.6pp

Artiva Biotherapeutics, Inc.ARTV

-101.9%—

IncyteINCY

62.6%+24.7pp

Kyverna Therapeutics, Inc.KYTX

-94.5%-4.6pp

FAQ

What is Iovance Biotherapeutics, Inc.'s return on invested capital?

Iovance Biotherapeutics, Inc. (IOVA) reported return on invested capital of -46.7% in Q2 2026.

How has Iovance Biotherapeutics, Inc.'s return on invested capital changed year-over-year?

Iovance Biotherapeutics, Inc.'s return on invested capital increased by 29.8% year-over-year, from -66.6% to -46.7%.

What is the long-term trend for Iovance Biotherapeutics, Inc.'s return on invested capital?

Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s return on invested capital has grown at a 3.1% compound annual growth rate (CAGR), from -55.9% to -65.2%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.